The referenced publication is a CASE REPORT in Frontiers in Immunology with the title indicating a phenotypic shift from active class IV lupus nephritis to lupus podocytopathy and emphasizing the treatment-altering role of repeat kidney biopsy. The title and article type were present on the journal site navigation and header information included in the retrieved source.
The content obtained from the provided source consisted primarily of journal navigation elements, section menus, and repeated page headers. The substantive article text — including abstract, introduction, case presentation, methods, results, histopathology descriptions, images, tables, and discussion — was not present in the supplied source. Therefore, no patient-level data, clinical measurements, or narrative details from the case report are available to summarize or rewrite.
The article title identifies three central concepts: lupus nephritis, lupus podocytopathy, and repeat kidney biopsy. These terms appear in the title as the primary focus of the case report. Beyond the title itself, the retrieved source did not provide further exposition or definitions related to these concepts, and no specific histologic, immunofluorescence, electron microscopy, laboratory, or treatment information was reported in the source content.
The entry is categorized as a CASE REPORT article in Frontiers in Immunology. The site navigation included journal sections and topics, indicating the journal’s scope and structure, but did not include the actual case report content. No authorship, institutional affiliations, publication date, DOI details beyond the title string, or acknowledgements were included in the downloaded source material except the journal header reference.
The following clinical elements commonly expected in a case report were not reported in the provided source and therefore cannot be restated or summarized here:
Because these details were not present in the source, they are not available for clinical synthesis or citation here.
The article title suggests an important clinical issue — that repeat kidney biopsy may reveal a phenotypic shift that alters treatment strategy — but the retrieved source does not provide the case evidence or rationale to support or explain that implication. Readers interested in the clinical findings, biopsy criteria, and management changes described in this case report will need to consult the full article on the publisher’s site or contact the journal for access. Specific next steps that follow from the missing content cannot be outlined from the supplied source.
No data availability, ethics approval, consent statements, or author declarations were present in the source material provided. As such, details about patient consent, ethics committee approval, or how data can be accessed were not reported in the retrieved content.
Conclusion
The available source page confirms only the article title and classification as a case report in Frontiers in Immunology. It does not include the case narrative, histopathologic data, management decisions, or outcomes. Therefore, no additional clinical facts, recommendations, or interpretations beyond the article title and the absence of content can be provided from this source. To extract and review the clinical details referenced in the title — including how a repeat kidney biopsy reportedly altered treatment when a phenotypic shift occurred from class IV lupus nephritis to lupus podocytopathy — access to the full article text is necessary.